Business Context and Reporting Period
This Form 8-K filing by IRADIMED CORP (NASDAQ: IRMD) reports on the Annual Meeting of Stockholders held on June 20, 2024. The filing details the outcomes of three specific proposals submitted to security holders for a vote.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on corporate governance voting results rather than financial performance data.
Material Changes and Voting Results
The following material events occurred at the Annual Meeting:
- Proposal 1: Election of Directors
- Stockholders elected five directors: Roger Susi, Monty Allen, Anthony Vuoto, Hilda Scharen-Guivel, and James Hawkins.
- All nominees received majority support, though vote counts varied. Anthony Vuoto and Hilda Scharen-Guivel received the highest "For" votes (over 10.7 million), while James Hawkins received the lowest (8.77 million).
- Broker non-votes totaled 709,160 for all director nominees.
- Proposal 2: Ratification of Auditors
- Stockholders ratified the selection of RSM US LLP as the independent registered public accounting firm for the fiscal year ending December 31, 2024.
- Votes For: 11,609,434; Votes Against: 13,044; Abstentions: 2,073.
- Proposal 3: Executive Compensation Advisory Vote
- Stockholders approved the advisory resolution on the compensation of named executive officers.
- Votes For: 10,684,897; Votes Against: 197,682; Abstentions: 32,812.
Guidance, Outlook, and Risks
The filing text does not provide a clear value for future guidance, management outlook, specific risks, contingencies, or unusual items. The document is limited to the reporting of the voting tallies.
Investor Verification Checklist
- Verify the tenure and background of the newly elected directors, particularly James Hawkins, who received the highest number of withheld votes.
- Confirm the engagement terms and scope of work with the newly ratified auditor, RSM US LLP.
- Review the company's proxy statement for detailed breakdowns of executive compensation that were subject to the advisory vote.
- Check subsequent filings (e.g., 10-Q or 10-K) for the financial metrics absent in this 8-K.